PMID: 16237276Oct 21, 2005Paper

Coagulation and fibrinolysis in human acute lung injury--new therapeutic targets?

The Keio Journal of Medicine
L B WareLing Wang

Abstract

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are common, life-threatening causes of acute respiratory failure that arise from a variety of local and systemic insults. The need for new specific therapies has led a number of investigators to examine the role of altered coagulation and fibrinolysis in the pathogenesis of ALI/ARDS. This review summarizes our current understanding of coagulation and fibrinolysis in human ALI/ARDS with an emphasis on pathways that could be potential therapeutic targets including the tissue factor pathway, the protein C pathway and modulation of fibrinolysis via plasminogen activator inhibitor-1. The available data suggest that clinical ALI and ARDS are characterized by profound alterations in both systemic and intra-alveolar coagulation and fibrinolysis. Fibrin deposition in the airspaces and lung microvasculature likely results from both activation of the coagulation cascade and impaired fibrinolysis, triggered by inflammation. Modulation of fibrin deposition in the lung through targeting activation and modulation of coagulation as well as fibrinolysis may be an important therapeutic target in clinical ALI/ARDS that deserves further exploration.

Associated Clinical Trials

References

Jan 1, 1977·Annual Review of Biochemistry·J Stenflo, J W Suttie
Apr 1, 1991·The American Journal of Physiology·T J GrossR G Sitrin
Oct 1, 1991·The American Journal of Physiology·S IdellR J Maunder
Nov 1, 1990·American Journal of Respiratory Cell and Molecular Biology·T J GrossR G Sitrin
Aug 1, 1989·The American Review of Respiratory Disease·R MoalliT Saldeen
Jun 1, 1993·The Journal of Clinical Investigation·A A CreaseyL B Hinshaw
Jan 1, 1996·American Journal of Respiratory and Critical Care Medicine·T Fuchs-BuderP M Suter
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·D J Stearns-KurosawaC T Esmon
May 20, 1998·Critical Care Medicine·B Krafte-Jacobs, R Brilli
Aug 5, 1998·The American Journal of Physiology·K TakahashiT Matsuoka
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
May 4, 2000·The New England Journal of Medicine·L B Ware, M A Matthay
Jun 17, 2000·Baillière's Best Practice & Research. Clinical Haematology·J H McVey
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·P EnkhbaatarY Yamaguchi
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Dec 6, 2001·American Journal of Respiratory and Critical Care Medicine·K E Welty-WolfC A Piantadosi
May 30, 2002·American Journal of Respiratory Cell and Molecular Biology·Debra L MillerClaude A Piantadosi
Jul 10, 2002·Lung·O HatajiY Adachi
Feb 21, 2003·The New England Journal of Medicine·Margaret S HerridgeUNKNOWN Canadian Critical Care Trials Group
Feb 26, 2003·American Journal of Respiratory Cell and Molecular Biology·Renli QiaoZea Borok
Apr 25, 2003·Intensive Care Medicine·Jean-François DhainautUNKNOWN Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group
Apr 26, 2003·American Journal of Respiratory and Critical Care Medicine·Martha Sue CarrawayClaude A Piantadosi
May 6, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Priya PrabhakaranMitchell A Olman
May 10, 2003·American Journal of Respiratory and Critical Care Medicine·Shino ShimizuKoji Suzuki
May 20, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Lorraine B WareMichael A Matthay
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Edward AbrahamUNKNOWN OPTIMIST Trial Study Group
Sep 13, 2003·Chest·Charles T Esmon
Oct 22, 2003·Intensive Care Medicine·Christian Brun-BuissonUNKNOWN ALIVE Study Group

❮ Previous
Next ❯

Citations

Nov 13, 2007·Intensive Care Medicine·John ArcaroliEdward Abraham
Jan 29, 2014·Vascular Pharmacology·Joyce N GonzalesEvgeny A Zemskov
Mar 17, 2016·Disease Markers·Raiko BlondonnetMatthieu Jabaudon
Aug 28, 2012·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Pin-Kuei FuChing-Liang Hsieh
Dec 4, 2014·Respiratory Physiology & Neurobiology·Daniela Mokra, Petra Kosutova
Mar 29, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Pin-Kuei FuChing-Liang Hsieh
Jun 10, 2010·FEMS Immunology and Medical Microbiology·In-Hwa YooUn-Hwan Ha
Sep 28, 2010·FEMS Immunology and Medical Microbiology·Hee-Sung ShinUn-Hwan Ha
Dec 3, 2010·Respiration; International Review of Thoracic Diseases·Shintaro HaraShigeru Kohno
May 2, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Lorraine B WareMichael A Matthay
Aug 22, 2007·Reproduction : the Official Journal of the Society for the Study of Fertility·Richard G Lea, Olivier Sandra
Apr 24, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Bernard J FisherRamesh Natarajan
Sep 5, 2020·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Samuel A Berkman, Victor F Tapson
Jan 6, 2017·Mediators of Inflammation·Ann Kristin Barton, Heidrun Gehlen
Jun 17, 2020·Research and Practice in Thrombosis and Haemostasis·Christopher D BarrettMichael B Yaffe
Jul 24, 2020·Critical Care : the Official Journal of the Critical Care Forum·Frank M P van HarenBarry Dixon
Oct 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xue-Qing WangEdward Abraham
May 11, 2017·Respiratory Research·Marta Camprubí-RimblasAntonio Artigas
Nov 26, 2020·International Journal of Molecular Sciences·Alice G VassiliouStylianos E Orfanos
Feb 7, 2021·Seminars in Respiratory and Critical Care Medicine·Samuel A Berkman, Victor F Tapson
Jul 1, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Christian BimeJoe G N Garcia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Claudio E LagoaWendy M Mars
Current Opinion in Infectious Diseases
Riana CockeranCharles Feldman
© 2021 Meta ULC. All rights reserved